Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin effect on postprandial GLP-1 secretion
NCT03018444Completed
- Sponsor
- Gentofte Hospital
- Start
- Oct 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hypercholesterolemia comparing Atorvastatin Sequence with Placebo Sequence (2 arms). Primary endpoint: Postprandial GLP-1 secretion. Started Oct 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT03018444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03018444.